Skip to main content
×
×
Home

The methamphetamine problem: Commentary on … Psychiatric morbidity and socio-occupational dysfunction in residents of a drug rehabilitation centre

  • Niall Galbraith (a1)
Summary

This paper introduces the reader to the characteristics of methamphetamine. Explored within are the drug's effects on those who consume it as well as the history and prevalence of its use. The highly addictive nature of methamphetamine is compounded by its affordability and the ease with which it is produced, with North America and East Asia having become established as heartlands for both consumption and manufacture. The paper discusses recent cultural depictions of the drug and also the role that mental health professionals may take in designing and delivering interventions to treat methamphetamine addiction.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      The methamphetamine problem
      Available formats
      ×
      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      The methamphetamine problem
      Available formats
      ×
      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      The methamphetamine problem
      Available formats
      ×
Copyright
This is an open-access article published by the Royal College of Psychiatrists and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Corresponding author
Correspondence to Niall Galbraith (n.galbraith@wlv.ac.uk)
Footnotes
Hide All

See original paper, pp. 213–217, this issue.

Declaration of interest

None.

Footnotes
References
Hide All
1 Brown, JM, Hanson, GR, Fleckenstein, AE. Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants. J Pharmacol Exp Ther 2001; 296: 762–7.
2 Fleckenstein, AE, Metzger, RR, Gibb, JW, Hanson, GR. A rapid and reversible change in dopamine transporters induced by methamphetamine. Eur J Pharmacology 1997; 323: R910.
3 Mantle, TJ, Tipton, KF, Garrett, NJ. Inhibition of monoamine oxidase by amphetamine and related compounds. Biochem Pharmacol 1976; 25: 2073–7.
4 Sulzer, D, Sonders, MS, Poulsen, NW, Galli, A. Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 2005; 75: 406–33.
5 Darke, S, Kaye, S, McKetin, R, Duflou, J. Major physical and psychological harms of methamphetamine use. Drug Alcohol Rev 2008; 27: 253.
6 McGregor, C, Srisurapanont, M, Jittiwutikarn, J, Laobhripatr, S, Wongtan, T, White, JM. The nature, time course and severity of methamphetamine withdrawal. Addiction 2005; 100: 1320–9.
7 Barr, AM, Panenka, WJ, MacEwan, GW, Thornton, AE, Lang, DJ, Honer, WG, et al. The need for speed: an update on methamphetamine addiction. J Psychiatr Neuroscience 2006; 31: 301.
8 Kaye, S, McKetin, R, Duflou, J, Darke, S. Methamphetamine and cardiovascular pathology: a review of the evidence. Addiction 2007; 102: 1204–11.
9 Shetty, V, Mooney, LJ, Zigler, CM, Belin, TR, Murphy, D, Rawson, R. The relationship between methamphetamine use and increased dental disease. J Am Dent Assoc 2010; 141: 307–18.
10 Rothrock, JF, Rubenstein, R, Lyden, PD. Ischemic stroke associated with methamphetamine inhalation. Neurology 1988; 38: 589–92.
11 Halkitis, PN, Parsons, JT, Stirratt, MJ. A double epidemic: crystal methamphetamine drug use in relation to HIV transmission. J Homosex 2001; 41: 1735.
12 Castro, FG, Barrington, EH, Walton, MA, Rawson, RA. Cocaine and methamphetamine: differential addiction rates. Psychology Addict Behav 2000; 14: 390.
13 Shoblock, JR, Maisonneuve, IM, Glick, SD. Differences between d-methamphetamine and d-amphetamine in rats: working memory, tolerance, and extinction. Psychopharmacol 2003; 170: 150–6.
14 Hser, YI, Huang, D, Brecht, ML, Li, L, Evans, E. Contrasting trajectories of heroin, cocaine, and methamphetamine use. J Addict Dis 2008; 27: 1321.
15 Cartier, J, Farabee, D, Prendergast, ML. Methamphetamine use, self-reported violent crime, and recidivism among offenders in California who abuse substances. J Interpers Violence 2006; 21: 435–45.
16 Sommers, I, Baskin, D, Baskin-Sommers, A. Methamphetamine use among young adults: health and social consequences. Addict Behav 2006; 31: 1469–76.
17 World Health Organization. Amphetamine-like Stimulants: A Report from the WHO Meeting on Amphetamines, MDMA and Other Psychostimulants, Geneva, 12–15 November 1996. WHO, 1997.
18 Miller, MA. History and epidemiology of amphetamine abuse in the United States. In Amphetamine Misuse: International Perspectives on Current Trends (ed. Klee, H): 113–34. Harwood Academic Publishers, 1997.
19 Potter, MJ, Kolbye, KE. Effects of D-Methamphetamine. National Drug Intelligence Center, 1996.
20 Office of National Drug Control Policy. Pulse Check: National Trends in Drug Abuse. ONDCP, 1997.
21 Centers for Disease Control and Prevention. Public health consequences among first responders to emergency events associated with illicit methamphetamine laboratories – selected states, 1996–1999. MMWR 2000; 49: 1021–4.
22 Kozel, N, Lund, J, Douglas, J, McKetin, R. Patterns and Trends in Amphetamine-Type Stimulants in East Asia and the Pacific 2006. United Nations Office on Drugs and Crime Regional Centre for East Asia and the Pacific, 2007.
23 Anglin, MD, Burke, C, Perrochet, B, Stamper, E, Dawud-Noursi, S. History of the methamphetamine problem. J Psychoact Drugs 2000; 32: 137–41.
24 Substance Abuse and Mental Health Services Administration. Results from the 2007 National Survey on Drug Use and Health: National Findings. Office of Applied Statistics, NSDUH Series H-34, DHHS Publication No. SMA 08-4343. SAMHSA, 2013.
25 United Nations Office on Drugs and Crime. 2007 World Drug Report. Volume 1: Analysis. United Nations Office on Drugs and Crime, 2007.
26 Devaney, M, Reid, G, Baldwin, S. Situational Analysis of Illicit Drug Issues and Responses in the Asia-Pacific Region. Australian National Council on Drugs, 2006.
27 United Nations Office on Drugs and Crime. Drug Abuse among Youth in Vientiane, School Survey. United Nations Office on Drugs and Crime Regional Centre for East Asia and the Pacific, 2002.
28 Griffiths, P, Mravcik, V, Lopez, D, Klempova, D. Quite a lot of smoke but very limited fire – the use of methamphetamine in Europe. Drug Alcohol Rev 2008; 27: 236–42.
29 Degenhardt, L, Roxburgh, A, Black, E, Bruno, RB, Campbell, G, Kinner, S, et al. The epidemiology of methamphetamine risk and harm in Australia. Drug Alcohol Rev 2008; 27: 243–52.
30 Plüddemann, A, Myers, BJ, Parry, CD. Surge in treatment admissions related to methamphetamine use in Cape Town, South Africa: implications for public health. Drug Alcohol Rev 2008; 27: 185–9.
31 Pluddemann, A, Flisher, AJ, Mathews, C, Carney, T, Lombard, C. Adolescent methamphetamine use and sexual risk behaviour in secondary school students in Cape Town, South Africa. Drug Alcohol Rev 2008; 7: 687–92.
32 Linnemann, T, Wall, T. ‘This is your face on meth’: the punitive spectacle of ‘white trash’ in the rural war on drugs. Theor Criminol 2013; 17: 315–34.
33 Hendrickson, RG, Cloutier, R, John McConnell, K. Methamphetamine-related emergency department utilization and cost. Acad Emerg Med 2008; 15: 2331.
34 Soames Job, RF. Effective and ineffective use of fear in health promotion campaigns. Am J Publ Health 1988; 78: 163–7.
35 Murakawa, N. Toothless. Du Bois Review: Soc Sci Res Race 2011; 8: 219–28.
36 Karila, L, Weinstein, A, Aubin, HJ, Benyamina, A, Reynaud, M, Batki, SL. Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol 2010; 69: 578–92.
37 Lee, NK, Rawson, RA. A systematic review of cognitive and behavioural therapies for methamphetamine dependence. Drug Alcohol Rev 2008; 27: 309–17.
38 Guyll, M, Spoth, R, Crowley, DM. Economic analysis of methamphetamine prevention effects and employer costs. J Studies Alcohol Drugs 2011; 72: 577.
39 Ettner, SL, Huang, D, Evans, E, Rose Ash, D, Hardy, M, Jourabchi, M, et al. Benefit-cost in the California Treatment Outcome Project: does substance abuse treatment ‘pay for itself’? Health Serv Res 2006; 41: 192213.
40 Dobkin, C, Nicosia, N. The war on drugs: methamphetamine, public health, and crime. Am Econ Rev 2009; 99: 324.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

BJPsych Bulletin
  • ISSN: 2056-4694
  • EISSN: 2056-4708
  • URL: /core/journals/bjpsych-bulletin
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 3
Total number of PDF views: 28 *
Loading metrics...

Abstract views

Total abstract views: 90 *
Loading metrics...

* Views captured on Cambridge Core between 2nd January 2018 - 22nd July 2018. This data will be updated every 24 hours.

The methamphetamine problem: Commentary on … Psychiatric morbidity and socio-occupational dysfunction in residents of a drug rehabilitation centre

  • Niall Galbraith (a1)
Submit a response

eLetters

Why isn't UK Breaking Bad?

Wiktor L Kulik, ST5 General Adult Psychiatry, Barts and The London Training Scheme, East London NHS Foundation Trust
14 October 2015

I recently finally got to see the pilot of the ‘Breaking Bad’ series. This coincided with two very interesting articles by Ho et al and Niall Galbraith in the October issue of BJPsych Bulletin (1) on methamphetamine use. And this made me reflect on my 1.5 years of experience in NHS addictions and a few more of working in mental health – methamphetamine use is rarely seen. I vividly remember one highly disinhibited patient and a few MSM (men who have sex with men) describing occasional use in a context of chemsex, but not much more than this.

The article describes that in the USA 4.7% of respondents to a national survey admit to lifetime use of methamphetamine (1). So why is it not as popular in the UK? Home office estimates (2012) indicate around 17000 users, whereas cannabis is estimated at around 2 million users in the UK. The author describes an already congested stimulant market in Europe and this obviously is an important factor. This market is served well by the availability of cocaine, MDMA, amphetamine, mephedrone and until recently ‘legal high’ stimulants. Gary Sutton of the charity Release is cited in a BBC article (2) saying that the lack of open spaces to produce the drug is a contributing factor. But surely if the demand was there then the same black market that supplies users of other substances would find a way. Some of the difference in popularity can be explained by a high price, but again this is mainly a result of small supply rather than excessive demand.

This also in part might be to do with the drug's reputation – that crystal meth has long lasting effects and unpleasant side effects, perhaps a success of the US ‘Faces of Meth’ campaign. But what I also found in discussion with patients is 'fashion'. I understood it when I realised that it is being used, with the users not always aware. Patients described taking crack or 'super crack' but tested negative for cocaine. A test for methamphetamine metabolites was however positive. An interesting case of creative branding by the black market, but people in the UK still drive Vauxhalls and often have separate taps for hot and cold water, so maybe we shouldn’t be surprised after all.

References:

1. Galbraith N, Commentary on…Psychiatric morbidity and socio-occupational dysfunction in residents of a drug rehabilitation centre. BJPsych Bulletin (2015), 39, 218-220

2. http://www.bbc.co.uk/news/magazine-23453028

... More

Conflict of interest: None Declared

Write a reply

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *